|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/352 | |
| A61K 36/185 | |||
| A61P 37/00 |
| (11) | Number of the document | 2182940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08762489.6 |
| Date of filing the European patent application | 2008-06-25 | |
| (97) | Date of publication of the European application | 2010-05-12 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2008/002183 |
| Date | 2008-06-25 |
| (87) | Number | WO 2009/004302 |
| Date | 2009-01-08 |
| (30) | Number | Date | Country code |
| 0713083 | 2007-07-05 | GB |
| (72) |
ROBSON, Philip, GB
GUY, Geoffrey, GB
PERTWEE, Roger, GB
JAMONTT, Joanna, GB
|
| (73) |
GW Pharma Limited,
Porton Down Science Park, Salisbury Wiltshire SP4 0JR,
GB
|
| (54) | USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |
| USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE |